Cutaneous Leishmaniasis Wound Healing with Cold Plasma

Investigating the effect of using atmospheric cold plasma radiation to heal wound healing in cutaneous leishmaniasis

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

IRCT

Registry ID

IRCT20160514027888N3

Enrollment

142

Registered

2023-04-17

Start date

2023-06-22

Completion date

Unknown

Last updated

2023-05-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cutaneous leishmaniasis. Cutaneous leishmaniasis

Interventions

Intervention 1: Control group: The standard treatment of Salk includes injection of glucantim ampoules. Intervention 2: Intervention group: Standard treatment along with plasma radiation during 10 alt

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: No history of radiation therapy. Not taking chemotherapy drugs. Not taking drugs that suppress the immune system. Not having a severe infection that requires hospitalization. Not having a severe bone infection Lack of breastfeeding.

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

Measure	Time frame
Changes in wound area and wound infection rate. Timepoint: Before treatment, after two weeks and at the end of treatment. Method of measurement: Imaging and microbial culture.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactAbolfazl Fattah

Semnan University of Medical Sciences

Drabolfazlfatah@gmail.com+98 23 3522 5120

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026